Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Research To Practice | Oncology Videos · Dr. Neil Love
August 16, 202348m 47s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Philip A Philip, including the following topics:
- Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00)
- Selection of first-line therapy for patients with metastatic CRC (mCRC) (7:51)
- Therapeutic options for patients with HER2-positive mCRC (10:10)
- Patient selection for regorafenib and/or TAS-102 with or without bevacizumab for mCRC (16:57)
- Selection and sequencing of therapeutic options for patients with unresectable or metastatic gastric or gastroesophageal junction cancer (19:52)
- Current and emerging immune checkpoint inhibitor-based combinations for hepatocellular carcinoma (24:51)
- First- and later-line therapy for patients with advanced biliary tract cancers (33:17)
- Activity of NALIRIFOX (liposomal irinotecan/oxaliplatin/leucovorin/fluorouracil) for treatment-naïve metastatic pancreatic cancer (36:12)